Publications
- Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe
- Feasibility of Point-of-Care Testing for Influenza Within a National Primary Care Sentinel Surveillance Network in England: Protocol for a Mixed Methods Study
- Investigating the procurement system for understanding seasonal influenza vaccine brand availability in Europe
- Moderate influenza vaccine effectiveness against A(H1N1)pdm09 virus, and low effectiveness against A(H3N2) subtype, 2018/19 season in Italy
- Comparison of the clinical characteristics and outcomes of hospitalized adult COVID-19 and influenza patients – a prospective observational study
- Integrating molecular point-of-care testing for influenza into primary care: a mixed-methods feasibility study
- Influenza Vaccination in Italian Healthcare Workers (2018–2019 Season): Strengths and Weaknesses. Results of a Cohort Study in Two Large Italian Hospitals
- Effectiveness of two influenza vaccines in nationwide cohorts of Finnish two-year-old children in the seasons 2015/16-2017/18
- Moderate vaccine effectiveness against severe acute respiratory infection caused by A(H1N1)pdm09 influenza virus and no effectiveness against A(H3N2) influenza virus in the 2018/19 season in Italy
- Seasonal influenza surveillance and vaccine effectiveness at a time of co-circulating COVID-19: Oxford-Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) and Public Health England (PHE) protocol for winter 2020/21
- Using Point of Care Testing to estimate influenza vaccine effectiveness in the English primary care sentinel surveillance network
- Challenges and Adaptation of a European Influenza Vaccine Effectiveness Study Platform in Response to the COVID-19 Emergence: Experience from the DRIVE Project
- Vaccine effectiveness against laboratory-confirmed influenza in Europe – Results from the DRIVE network during season 2018/19
- Brand-specific influenza vaccine effectiveness estimates during 2019/20 season in Europe – Results from the DRIVE EU study platform
- Factors driving choices between types and brands of influenza vaccines in general practice in Austria, Italy, Spain and the UK
- Temporal Properties of Vaccine Effectiveness Measures in Presence of Multiple Pathogen Variants and Multiple Vaccines
- DRIVE in short: Summary of projects, main accomplishments and key lessons learnt
- The value of public-private collaborative Real-World Evidence platforms to monitor vaccine performance post authorization: DRIVE – a European initiative
- Investigating confounding in network-based test-negative design influenza vaccine effectiveness studies—Experience from the DRIVE project